Antibodies under a microscope

Ab02436-11.0

Anti-CD80 [1F1], Human IgG2, kappa

Description

Recombinant monoclonal antibody to CD80. Manufactured using AbAb’s Recombinant Platform with variable regions (i.e. specificity) from the hybridoma 1F1.

Target

CD80

Target Alias Names

B7.1, CD28L, CD28LG, B7-1, B7, BB1, B7/BB1, T-lymphocyte activation antigen CD80, Activation B7-1 antigen, CTLA-4 counter-receptor B7.1, CTLA4L, CTLA-4L

Isotype/Mimetic

IgG2

Animal-Derived Biomaterials Used

No

Sequence Available

No

Original Discovery Methods

Naïve display libraries derived from human B cells, or naïve display libraries from animal B cells or Display libraries from synthetic or natural framework sequences

Original Discovery Information Provided On Datasheet

Yes

Antibody/Binder Origins

Animal-free discovery, Animal-dependent discovery (in vitro display, OR immunisation pre-2020), In vitro recombinant expression